Sponsored Links
| Lymphoseek(R) (Tilmanocept) Meets All Endpoints In Neo3-09 Phase 3 Study |
 |
 |
 |
| Medical News - Lymphology and Lymphedema | |||
|
Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology diagnostic products, today announced top-line results from its Lymphoseek(R) (tilmanocept) NEO3-09 study... Read more: Lymphology/Lymphedema News From Medical News Today
|